1. Home
  2. Analysis
  3. Effexor
  4. Moviprep

Effexor and Moviprep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 26 people who take Effexor and Moviprep. Common interactions include deep vein thrombosis among females, and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people who take Effexor and Moviprep have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

26 people who take Effexor and Moviprep together, and have interactions are studied.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is used in depression. Currently, eHealthMe is studying from 97,783 Effexor users.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is used in colonoscopy abnormal. Currently, eHealthMe is studying from 3,096 Moviprep users.

Number of Effexor and Moviprep reports submitted per year:

Effexor and Moviprep drug interactions.

Common Effexor and Moviprep drug interactions by gender *:

female:

  1. Deep vein thrombosis
  2. Dyspnoea
  3. Gastrointestinal obstruction
  4. Weight decreased
  5. Alopecia
  6. Anaemia
  7. Dizziness
  8. Dysgeusia
  9. Hair colour changes
  10. Hair disorder

male:

  1. General physical health deterioration
  2. Amnesia
  3. Eye movement disorder
  4. Fatigue
  5. Headache
  6. Hemiparesis
  7. Injury
  8. Loss of consciousness
  9. Malaise
  10. Nausea

Common Effexor and Moviprep drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Coma
  3. Gastrooesophageal reflux disease
  4. Lung disorder
  5. Nephrogenic anaemia
  6. Renal failure
  7. Renal failure acute
  8. Rhabdomyolysis

50-59:

  1. Deep vein thrombosis
  2. Gastrointestinal obstruction
  3. Anaemia
  4. Dyspnoea
  5. Ileus
  6. Pneumonitis
  7. Burning sensation
  8. Cough
  9. Dizziness
  10. Face oedema

60+:

  1. General physical health deterioration
  2. Asthenia
  3. Eye movement disorder
  4. Fatigue
  5. Headache
  6. Hemiparesis
  7. Injury
  8. Loss of consciousness
  9. Malaise
  10. Nausea

Common conditions people have *:

  1. Pain: 11 people, 42.31%
  2. High Blood Pressure: 7 people, 26.92%
  3. Ill-Defined Disorder: 5 people, 19.23%
  4. Hot Flush (sudden feelings of heat): 5 people, 19.23%
  5. Constipation: 5 people, 19.23%
  6. Nausea (feeling of having an urge to vomit): 5 people, 19.23%
  7. Asthma: 4 people, 15.38%
  8. Stress And Anxiety: 3 people, 11.54%
  9. Indigestion: 2 people, 7.69%
  10. Insomnia (sleeplessness): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Moviprep?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Effexor drug interactions:

Browse interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Moviprep drug interactions:

Browse interactions between Moviprep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Effexor and Moviprep, respectively), and Effexor and Moviprep (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Effexor and Moviprep.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.